Imidazole → HCID 70980765, compound
Reaction equation
Br[CH2:2][C:3]1[O:7][N:6]=[C:5]([C:8]([NH:10][C@@H:11]([CH3:28])[CH2:12][N:13]2[CH:17]=[CH:16][C:15]([C:18]3[CH:23]=[C:22]([F:24])[C:21]([C:25]#[N:26])=[C:20]([Cl:27])[CH:19]=3)=[N:14]2)=[O:9])[CH:4]=1.[NH:29]1[CH:33]=[CH:32][N:31]=[CH:30]1>CN(C=O)C.CCOC(C)=O>[N:29]1([CH2:2][C:3]2[O:7][N:6]=[C:5]([C:8]([NH:10][C@@H:11]([CH3:28])[CH2:12][N:13]3[CH:17]=[CH:16][C:15]([C:18]4[CH:23]=[C:22]([F:24])[C:21]([C:25]#[N:26])=[C:20]([Cl:27])[CH:19]=4)=[N:14]3)=[O:9])[CH:4]=2)[CH:33]=[CH:32][N:31]=[CH:30]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
(S)-5-(Bromomethyl)-N-(1-(3-(3-chloro-4-cyano-5-fluorophenyl)-1H-pyrazol-1-yl)propan-2-yl)isoxazole-3-carboxamide (0.137 mmol, 0.064 g) was suspended in DMF (5 ml). Imidazole (2.74 mmol, 0.187 g) was added and the resulting mixture was stirred at RT for 2.5 h. The reaction mixture was heated to 60° C. for 1.5 h. The mixture was diluted with EtOAc and washed four times with water. The organic phase was dried, filtered and evaporated. The crude product was purified by preparative HPLC. 0.017 g of the title compound was obtained. 1H-NMR (400 MHz, DMSO-d6): δ 1.15 (d, 3H), 4.31 (d, 2H), 4.37-4.50 (m, 1H), 5.50 (s, 2H), 6.63 (s, 1H), 6.94 (s, 1H), 6.99 (d, 1H), 7.22-7.24 (m, 1H), 7.76 (s, 1H), 7.83 (d, 1H), 7.84-7.88 (m, 1H), 7.96 (s, 1H), 8.81 (d, 1H).
Workup
- temperatureThe reaction mixture was heated to 60° C. for 1.5 h
- washwashed four times with water
- customThe organic phase was dried
- filtrationfiltered
- customevaporated
- customThe crude product was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-c42b63c0a1f74ef09fc9096a0e95270f
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08921378B2
Reaction notes
Loading…